NasdaqCM - Nasdaq Real Time Price USD

Dogwood Therapeutics, Inc. (DWTX)

5.58
-0.02
(-0.33%)
As of 11:04:47 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
15,343.07
12,227.25
5,446.92
12,315.31
15,640.94
Operating Income
-15,343.07
-12,227.25
-5,446.92
-12,315.31
-15,640.94
Net Non Operating Interest Income Expense
-262.05
-92.19
150.90
67.48
5.67
Other Income Expense
--
-30.79
--
--
-325
Pretax Income
-21,793.30
-12,350.23
-5,296.02
-12,247.83
-15,960.27
Tax Provision
190.04
-0.50
0
0
0
Net Income Common Stockholders
-23,240
-12,349.72
-5,296.02
-12,247.83
-15,960.27
Diluted NI Available to Com Stockholders
-23,240
-12,349.72
-5,296.02
-12,247.83
-15,960.27
Basic EPS
-19.29
-12.52
-7.00
-27.75
-48.00
Diluted EPS
-19.29
-12.52
-7.00
-27.75
-48.00
Basic Average Shares
1,195.59
1,027.79
751.07
442.80
333.17
Diluted Average Shares
1,195.59
1,027.79
751.07
442.80
333.17
Total Operating Income as Reported
-15,343.07
-12,227.25
-5,446.92
-12,315.31
-15,640.94
Total Expenses
15,343.07
12,227.25
5,446.92
12,315.31
15,640.94
Net Income from Continuing & Discontinued Operation
-21,983.34
-12,349.72
-5,296.02
-12,247.83
-15,960.27
Normalized Income
-17,094.68
-12,318.94
-5,296.02
-12,247.83
-15,960.27
Interest Income
--
--
150.90
67.48
--
Interest Expense
--
92.19
--
--
--
Net Interest Income
-262.05
-92.19
150.90
67.48
5.67
EBIT
-15,373.86
-12,258.04
-5,446.92
-12,315.31
-15,640.94
EBITDA
-15,344.66
-12,245.86
-5,446.92
-12,315.31
-15,640.94
Reconciled Depreciation
29.20
12.18
0
--
--
Net Income from Continuing Operation Net Minority Interest
-21,983.34
-12,349.72
-5,296.02
-12,247.83
-15,960.27
Total Unusual Items Excluding Goodwill
-6,188.18
-30.79
--
--
--
Total Unusual Items
-6,188.18
-30.79
--
--
--
Normalized EBITDA
-9,156.48
-12,215.07
-5,446.92
-12,315.31
-15,640.94
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,299.52
-0
0
0
0
12/31/2021 - 12/17/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CRVO CervoMed Inc.
7.46
-1.71%
 
SNTI Senti Biosciences, Inc.
3.1101
-1.27%
 
PRTG Portage Biotech Inc.
8.13
+1.75%
 
PHIO Phio Pharmaceuticals Corp.
2.1000
+0.48%
 
SXTP 60 Degrees Pharmaceuticals, Inc.
3.0400
+4.47%
 
VRAX Virax Biolabs Group Limited
1.0010
0.00%
 
SLXN Silexion Therapeutics Corp
0.9320
-1.95%
 
AEON AEON Biopharma, Inc.
0.6086
+3.27%
 
ADTX Aditxt, Inc.
1.5200
-0.65%
 
BDRX Biodexa Pharmaceuticals Plc
1.1301
-2.58%